CA 15-3 et cancers du sein-Reference-Cited by-同舟云学术

CA 15-3 et cancers du sein

Published:1994 Issue:10 Volume:15 Page:650-662
ISSN:0248-8663
Container-title:La Revue de Médecine Interne
language:fr
Short-container-title:La Revue de Médecine Interne

Author:

Antoine E,Kayitalire L,Spielmann M

Publisher

Elsevier BV

Subject

Gastroenterology,Internal Medicine

Reference62 articles.

1. Development and evaluation of a radioimmunoassay for the detection of a monoclonal antibody defined breast tumor associated antigen 115 D8/DF3;Tobias,1985

2. Comparison of circulating CA 15-3 and carcinoembryonic antigen levels in patients with breast cancer;Hayes;J Clin Oncol,1986

3. CEA vs CA 15-3 as markers for metastasized breast cancer. [Abstract];Namer,1986

4. CA 15-3 as a tumor marker in breast cancer;Schmidt-Rhode;Int J Biol Markers,1987

5. Circulating CA 15-3 levels in the post-surgical follow-up of breast cancer patients and in non-malignant diseases;Colomer;Breast Cancer Res Treat,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates;SAGE Open Medicine;2022-01

2. Intérêt des marqueurs tumoraux : quelle place pour l’ACE et le CA 15-3 ?;Médecine Nucléaire;2010-01

3. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients;British Journal of Cancer;2009-04

4. Marqueurs protéiques circulants et cancer du sein;Gynécologie Obstétrique & Fertilité;2006-07

5. Can tumour marker assays be a guide in the prescription of bone scan for breast and lung cancers?;European Journal of Nuclear Medicine and Molecular Imaging;1999-01-01